ENPP2 and breast angiosarcoma: From those findings, we observe that hepatic ATX expression was associated with an adverse clinical outcome in BA, which lends support to the hypothesis that inhibiting ATX as part of an antifibrotic model could serve as a novel therapeutic approach for treatment of hepatic fibrosis in BA patients.